Governance
Representing the voices of cancer research across Oxford, Oxford Cancer is committed to open and transparent communication with its members and our governance structure reflects this.
The Oxford Cancer Committees include representation from across the full breadth of activity in Oxford. We strive to ensure that the voice of each area of cancer research is represented in our committee structures. In turn, those representatives are not only charged with being ambassadors for their area of expertise but also for the Oxford Cancer network, bringing in more members and expanding the reach of our network.
Through its governance, Oxford Cancer coordinates new initiatives and provides the forum for consensus-building about the overall strategic direction for Oxford, providing a framework in which the individual aims and ambitions of the various constituent parts of the Oxford Cancer network can thrive while being united for maximum impact.
Chair: Professor Mark Middleton & Professor Tim Elliott
Remit: The Governance Board has the responsibility to oversee, develop, adjust, and approve the strategy of the Centre, including its training programmes. It serves as a decision-making forum to capitalise on strategically important opportunities. Additionally, the board discusses and agrees upon recruitment strategies for the Centre. It ensures the delivery of the Centre's strategy and objectives and verifies that the Centre's branding, press, and research engagement activities align with CRUK's expectations. Furthermore, the Governance Board reviews the Centre's performance and its contribution to the CRUK Centres Network, as well as addresses top-level financial opportunities and challenges. It also evaluates key initiatives proposed by CRUK, Research Councils, the NHS, and other organisations funding cancer research, and assesses the Centre's responses to them.
Committee Members:
- Professor Xin Lu
- Professor Gavin Screaton
- Professor Keith Channon
- Professor Freddie Hamdy
- Professor Helen McShane
- Professor Heidi Johansen-Berg
- Professor Ketan Patel
- Professor Meghana Pandit (Interim)
- Professor Adrian Banning
- Associate Professor Chris Cunningham
- Dr Andy Peniket
- Associate Professor Pankaj Roy
- Alex Pemberton
- Leila Whitworth
- Chris Price
- Dr. Elizabeth Mann
- Sophie De Gouveia
- Dr. Michael Youdell
Co-Directors: Professor Mark Middleton & Professor Tim Elliott
Remit: To determine the strategic direction of Oxford Cancer and to monitor its progress.
Committee Members:
- Professor Chris Holmes
- Professor Yvonne Jones
- Professor Paul Klenerman
- Professor Tim Maughan
- Professor Jordan Raff
- Professor Paresh Vyas
- Professor Simon Leedham
Chair: Professor Adrian Harris
Deputy Chair: Professor Chris Schofield
Remit: To integrate different perspectives and activities from across the cancer research community in a forum which can advise on implications to the Oxford Cancer strategy. The committee is also responsible for overseeing the distribution of the Development Fund scheme and coordinating networking activities for Oxford Cancer.
Committee Members:
- Professor Adrian Harris
- Dr Dragana Ahel
- Professor Ahmed Ahmed
- Dr Richard Bryant
- Dr Francesca Buffa
- Professor Robert Carlisle
- Dr Deborah Goberdhan
- Dr Eric O’Neill
- Professor Francis Szele
- Professor Paresh Vyas
- Prof Chris Scofield
- Prof Nick Lakin
- Prof David Dodwell
- Prof Natalia Gromak